Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en

Journal of Virology

Volumn 71, Issue 5, 1997, Pages 3385-3390

  Gubareva, Larisa V ^a   Robinson, Matthew J ^a   Bethell, Richard C ^b   Webster, Robert G ^a,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 GUANIDINOBUTYRIC ACID; SIALIDASE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CATALYSIS; CONFORMATIONAL TRANSITION; CROSS RESISTANCE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; FRAMESHIFT MUTATION; HUMAN; INFLUENZA VIRUS; PRIORITY JOURNAL; TARGET CELL; VIRUS INFECTION;

EID: 0031000886     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.5.3385-3390.1997     Document Type: Article

References (34)

1. Air, G. M., and W. G. Laver. 1989. The neuraminidase of influenza virus. Proteins Struct. Funct. Genet. 6:341-356. (Review.)
2. Aymard-Henry, M., M. T. Coleman, W. R. Dowdle, W. G. Laver, G. C. Schild, and R. G. Webster. 1973. Influenza virus neuraminidase-inhibition test procedures. Bull. W.H.O. 48:199-202.
3. Baker, A. T., J. N. Varghese, W. G. Laver, G. M. Air, and P. M. Colman. 1987. The three dimensional structure of neuraminidase of subtype N9 from an avian influenza virus. Proteins Struct. Funct. Genet. 2:111-117.
4. Bean, W. J., S. C. Threlkeld, and R. G. Webster. 1989. Biologic potential of amantadine-resistant influenza A virus in an avian model. J. Infect. Dis. 159:1050-1057.
5. Blick, T. J., T. Tiong, A. Sahasrabudhe, J. N. Varghese, P. M. Colman, G. J. Hart, R. C. Bethell, and J. L. McKimm-Breschkin. 1995. Generation and characterization of an influenza virus variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en. Virology 214:475-484.
6. Bossart-Whitaker, P., M. Carson, Y. S. Babu, S. D. Smith, W. G. Laver, and G. M. Air. 1993. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-dcoxy-2,3-dehydro-N-acetyl neuraminic acid. J. Mol. Biol. 232:1069-1083.
7. Burmeister, W. P., B. Henrissat, B., C. Bosso, S. Cusack, and R. W. H. Ruigrok. 1993. Influenza B virus neuraminidase can synthesize its own inhibitor. Structure 1:19-26.
8. Colman, P. M., P. A. Hoyne, and M. C. Lawrence. 1993. Sequence and structure alignment of paramyxovirus hemagglutinin-neurammidase with influenza virus neuraminidase. J. Virol. 67:2972-2980.
9. Colman, P. M. 1994. Influenza virus neuraminidase: structure, antibodies, and inhibitors. Protein Sci. 3:1687-1696. (Review.)
10. Crennell, S. J., E. F. Garman, W. G. Laver, E. R. Vimb, and G. L. Taylor. 1993. Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase. Proc. Natl. Acad. Sci. USA 90:9852-9856.
11. Goto, H., R. C. Bethell, and Y. Kawaoka. 1996. Mutations in the influenza neuraminidase affecting sensitivity to 4-guanidino-Neu5Ac2en, abstr. W-23-6. p. 123. In Abstracts of the 15th Meeting of the American Society for Virology. American Society for Virology, London, Ontario, Canada.
12. Gubareva, L. V., C. R. Penn, and R. G. Webster. 1995. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid. Virology 212:323-330.
13. Gubareva, L. V., R. Bethell, G. J. Hart, K. G. Murti, C. R. Penn, and R. G. Webster. 1996. Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. J. Virol. 70:1818-1827.
14. Hayden, F. G., K. M. Cote, and R. G., Douglas, Jr. 1980. Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob. Agents Chemother. 17:865-870.
15. Hayden, F. G., J. J. Treanor, R. F. Betts, M. Lobo, J. D. Esinhart, and E. K. Hussey. 1996. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA 275:295-300.
16. Lentz, M. R., R. G. Webster, and G. M. Air. 1987. Site-directed mutation of the active site of influenza neuraminidase and implications for the catalytic mechanism. Biochemistry 26:5351-5358.
17. Liu, C., M. D. Eichelberger, R. W. Compans, and G. M. Air. 1995. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J. Virol. 69:1099-1106.
18. McKimm-Breschkin, J. L., M. McDonald, T. J. Blick, and P. M. Colman. 1996. Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme. Virology 225:240-242.
19. Palese, P., and R. W. Compans. 1976. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoro-acetyl-neuraminic acid (FANA): mechanism of action. J. Gen. Virol. 33:159-163.
20. Palese, P., and J. L. Schulman. 1977. Inhibitors of viral neuraminidase as potential antiviral drugs, p. 189-205. In J. S. Oxford (ed.), Chemoprophylaxis and virus infections of the respiratory tract. CRC Press, Inc., Cleveland, Ohio.
21. Paulson, J. C., J. Weinstein, L. Dorland, H. Van Halbeek, and J. F. G. Vliegenthart. 1982. Newcastle disease virus contains a linkage-specific glycoprotein sialidase. J. Biol. Chem. 257:12734-12738.
22. Ryan, D. M., J. Ticehurst, M. H. Dempsey, and C. R. Penn. 1994. Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase). Antimicrob. Agents Chemother. 38:2270-2275.
23. Ryan, D. M., J. Ticehurst, and M. H. Dempsey. 1995. GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets. Antimicrob. Agents Chemother. 39:2583-2584.
24. Staschke, K. A., J. M. Colacino, A. J. Baxter, G. M. Air, A. Bansal, W. J. Hornback, J. E. Munroe, and W. G. Laver. 1995. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en. Virology 214: 642-646.
25. Taylor, N. R., and M. von Itzstein. 1994. Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis. J. Med. Chem. 37:616-624.
26. Varghese, J. N., and P. M. Colman. 1991. Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 Å resolution. J. Med. Biol. 221:473-486.
27. Varghese, J. N., W. G. Laver, and P. M. Colman. 1983. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature (London) 303:35-40.
28. Varghese, J. N., J. L. McKimm-Breschkin, J. B. Caldwell, A. A. Kortt, and P. M. Colman. 1992. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins Struct. Funct. Genet. 14:327-332.
29. Varghese, J. N., V. C. Epa, and P. M. Colman. 1995. Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase. Protein Sci. 4:1081-1087.
30. von Itzstein, M., W.-Y. We, G. B. Kok, M. S. Pegg, J. C. Dyason, B. Jim, T. Van Phan, M. L. Smythe, H. F. White, S. W. Oliver, P. M. Colman, J. N. Varghese, D. M. Ryan, T. G. Woods, R. C. Bethell, V. J. Hotham, J. M. Cameron, and C. R. Penn. 1993. Rational design of potent sialidase-based inhibitors of influenza virus protection. Nature (London) 363:418-423.
31. White, C. L., M. N. Janakiraman, W. G. Laver, C. Philippon, A. Vasella, G. M. Air, and M. Luo. 1995. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. J. Mol. Biol. 245:623-634.
32. Warner, T. G., and J. S. O'Brien. 1979. Synthesis of 2́-(4-methylubelliferyl)-α-D-N-acetylneuraminic acid and detection of skin fibroblast neuraminidase in normal humans and in sialidosis. Biochemistry 18:2783-2787.
33. Webster, R. G. 1970. Antigenic hybrids of influenza A viruses with surface antigens to order. Virology 42:633-642.
34. Woods, J. M., R. C. Bethell, J. A. V. Coates, N. Healy, S. A. Hiscox, B. A. Pearson, D. M. Ryan, J. Ticehirst, J. Tilling, S. M. Walcott, and C. R. Penn. 1993. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Chemother. 37:1473-1479.